A high-throughput genotyping platform showed that squamous cell carcinoma and adenocarcinoma have distinct molecular profiles; KRAS mutations were identified only in adenocarcinoma and EGFR mutation was detected only in squamous cell carcinoma [28]. The gene discussed is EGFR; the disease is adenocarcinoma.